Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women

Journal of Musculoskeletal Neuronal Interactions

Volumn 4, Issue 1, 2004, Pages 50-63

  Garnero, Patrick ^a   Delmas, P D ^a  

^a INSERM   (France)

Author keywords

Bone markers; Bone mineral density; Fracture; Osteoporosis; Type I collagen

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; ASPARTIC ACID DERIVATIVE; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; MATRIX PROTEIN; OSTEOCALCIN; SUCCINIMIDE DERIVATIVE;

AGE DISTRIBUTION; ARTICLE; BIOCHEMISTRY; BONE DENSITY; BONE MATRIX; BONE MINERAL; BONE STRENGTH; BONE TURNOVER; CHEMICAL STRUCTURE; COMPETENCE; CORTICAL BONE; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISOMERIZATION; MECHANICAL STRESS; MEDICAL DECISION MAKING; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PREDICTION; PROSPECTIVE STUDY; PROTEIN PROCESSING; PROTEIN URINE LEVEL; RISK ASSESSMENT; SCORING SYSTEM; SPINE FRACTURE; TREATMENT PLANNING;

BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE MATRIX; FEMALE; FRACTURES, BONE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 2642562195     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Anonymous. Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993; 94:646-650.
2. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Brit Med J 1996; 312:1254-1259.
3. Kanis JA, Gluer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 2000; 11:192-202.
4. Broe KD, Hannan MT, Kiely DK, Cali CM, Cupples LA, Kiel DP. Predicting fractures using bone mineral density: a prospective study of long-term care residents. Osteoporos Int 2000; 11:765-771.
5. Melton LJ, Crowson CS, O'Fallon WM, Wahner HW, Riggs BL. Relative contributions of bone density, bone turnover and clinical risk factors to long-term fracture predictions. J Bone Miner Res 2003; 18:312-318.
6. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley, Black D, Vogt TM. Risk factors for hip fracture in white women. N Engl J Med 1995; 332:767-773.
7. Miller PD, Siris ES, Barret-Connor E, Faulkner KG, Wehren LE, Abbott TA, Chen Y-T, Berger ML, Santora AC, Sherwood LM. Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: Evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res 2002; 17:2222-2230.
8. Bouxsein ML, Palermo L, Yeung C, Black DM. Digital X-ray radiogrammetry predicts hip, wrist and vertebral fracture risks in elderly women. A prospective analysis from the study of osteoporotic fractures. Osteoporos Int 2002; 13:358-365.
9. Schott AM, Cormier C, Hans D, Favier F, Hausherr e, Dargent-Molina P, Delmas PD, Ribot C, Sebert JL, Breart G, Meunier PJ. How hip and whole body bone mineral density predict hip fracture in elderly women: the EPIDOS prospective study. Osteoporos Int 1998; 8:247-254.
10. Duboeuf F, Hans D, Schott AM, Kolzki PO, Favier F, Marcelli C, Meunier PJ, Delmas PD. Different morphometric and densitometric parameters predict cervical and trochanteric hip fracture: the EPIDOS study. J Bone Miner Res 1997; 12:1895-1902.
11. Bolotin HH, Sievänen H, Grashuis JL, Kuiper JW, Järvinen TLN. Inaccuracies inherent in patients-specific dual energy X-ray absorptiometry bone mineral density measurements: Comprehensive phantom-based evaluation. J Bone Miner Res 2001; 16:417-426.
12. Bolotin HH. Inaccuracies inherent in dual-energy X-ray absorptiometry in vivo bone mineral densitometry may flaw osteopenic/osteoporotic interpretations and mislead assessment of antiresorptive effectiveness. Bone 2001; 28:548-555.
13. Bolotin HH, Sievänen H, Grashuis JL. Patient-specific DXA bone mineral density inaccuracies: Quantitative effects of nonuniform extraosseous fat distributions. J Bone Miner Res 2003; 18:1020-1027.
14. Muller ME, Webber CE, Bouxtein ML. Predicting the failure load of the distal radius. Osteoporos Int 2003; 14:345-352.
15. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 1996; 11:1531-1538.
16. Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, Ettinger B. Endogenous hormones and the risk of hip and vertebral fractures among older women. N Engl J Med 1998; 339:733-738.
17. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study. J Bone Miner Res 2000; 15:1526-1536.
18. Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC. Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 1996; 97:14-21.
19. Chapurlat RD, Garnero P, Bréart G, Meunier PJ, Delmas PD. Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: The EPIDOS study. J Bone Miner Res 2000; 15:1835-1841.
20. Tomkinson A, Reeve J, Shaw RW, Noble BS. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 1997; 82:3128-3135.
21. Dunstan CR, Evans RA, Hills E, Wong SYP, Higgs RJED. Bone death in hip fracture in the elderly. Calcif Tissue Int 1990; 47:270-275.
22. Garnero P, Delmas PD. Investigation of Bone. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Bone Turnover in Rheumatology, 3rd edition, Harcourt Health Sciences Ltd, London, UK; (in press).
23. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996; 11:337-349.
24. Stepan JJ. Prediction of bone loss in postmenopausal women. Osteoporos Int 2000; 11(Suppl 6):S45-S54.
25. Johansen JS, Riis BJ, Delmas PD, Christiansen C. Plasma BGP: an indicator of spontaneous bone loss and effect of estrogen treatment in postmenopausal women. Eur J Clin Invest 1988; 18:191-195.
26. Garnero P, Somay Rendu E, Duboeuf F, Delmas PD. Markers of bone turnover predict postmenopausal bone loss over 4 years: The OFELY study. J Bone Miner Res 1999; 14:399-406.
27. Ross PD, Knowlton W. Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 1998; 13:297-302.
28. Hansen MA, Kirsten O, Riss BJ, Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 years study. Brit Med J 1991; 303:961-964.
29. Albrand G, Munoz F, Sornay-Rendu E, Duboeuf F, Delmas PD. Independent predictors of all osteoporotic-related fractures in healthy postmenopausal women: The OFELY study. Bone 2003; 32:78-85.
30. Garnero P. Markers of bone turnover for the prediction of fracture risk. Osteoporos Int 2000; 11(Suppl 6):S55-S65.
31. Ingle BM, Hay SM, Bottjer HM, Eastell R. Changes in bone mass and bone turnover following distal forearm fracture. Osteoporos Int 1999; 10:399-407.
32. Akesson K, Vergnaud P, Gineyts E, Delmas PD, Obrant K. Impairment of bone turnover in elderly women with hip fracture. Calcif Tissue Int 1993; 53:162-169.
33. Riis SBJ, Hansen AM, Jensen K, Overgaard K, Christiansen C. Low bone mass and fast rate of bone loss at menopause-equal risk factors for future fracture. A 15 year follow-up study. Bone 1996; 19:9-12.
34. Ross PD, Kress BC, Parson RE, Wasnich RD, Armour KA, Mizrahi IA. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: A prospective study. Osteoporos Int 2000; 11:76-82.
35. van Daele PLA, Seibel MJ, Burger H, Hofman A, Grobbee DE, van Leeuwen JPTM, Birkenhager JC, Pols HAP. Case-control analysis of bone resorption markers, disability, and hip fracture risk: The Rotterdam study. Brit Med J 1996; 312:482-483.
36. Qvist P, Christgau S, Pedersen BJ, Schlemmer A, Christiansen C. Circadian variation in the serum C-terminal telopeptide of type I collagen (Serum CTx): Effects of gender, age, menopausal status, posture, daylight, serum cortisol and fasting. Bone 2002; 31:57-61.
37. Bjarnason NH, Henriksen EE, Alexandersen P, Christgau S, Henriksen DB, Christiansen C. Mechanism of circadian variation in bone resorption. Bone 2002; 30:307-313.
38. Clowes JA, Allen HC, Prentis R, Eastell R, Blumsohn A. Effect of octreotide on bone turnover and parathyroid hormone after oral glucose: Evidence for a novel endocrine interaction between the gastrointestinal tract and bone. J Clin Endocrinol (in press).
39. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J. The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 2000; 11(Suppl 6): S2-S17.
40. Chapurlat RD, Garnero P, Breart G, Meunier PJ, Delmas PD. Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. Bone 2000; 27:283-286.
41. Bauer DC, Black DM, Ensrud K, Qvist P, Williams E. Serum markers of bone turnover and fractures of the hip and spine: A prospective study. J Bone Miner Res 1999; 14(Suppl 1):S147.
42. Batge B, Deibold J, Stein H, Bodo M, Muller PK. Compositional analysis of the collagenous bone matrix-A study on adult normal and osteopenic bone tissue. Eur J Clin Invest 1992; 22:805-812.
43. Kowitz J, Knippel M, Schuhr T, Mach J. Alteration in the extent of collagen I hydroxylation, isolated from femoral heads of women with a femoral neck fracture caused by osteoporosis. Calcif Tissue Int 1992; 60:501-505.
44. Bailey AJ, Wotton SF, Sims TJ, Thompson PW. Post-translational modifications in the collagen of human osteoporotic femoral head. Biochem Biophys Res Commun 1992; 185:801-805.
45. Oxlund H, Moselkilde L, Ortoft G. Reduced concentration of collagen reducible cross-links in human trabecular bone with respect to age and osteoporosis. Bone 1996; 19:479-484.
46. Banse X, Sims TJ, Bailey AJ. Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links. J Bone Miner Res 2002; 17:1621-1628.
47. Wang X, Shen X, Li X, Agrawal CM. Age-related changes in collagen network and toughness of bone. Bone 2002, 31:1-7.
48. Cloos PAC, Fledelius C. Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential. Biochem J 2000; 345:473-480.
49. Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD. Decreased beta-isomerisation of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone. J Bone Miner Res 1997; 12:1407-1415.
50. Garnero P, Gineyts E, Shaffer AV, Seaman S, Delmas PD. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease. Arthritis Rheum 1998; 41:354-360.
51. Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: The OFELY prospective study. J Bone Miner Res 2002; 17:826-833.
52. Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar spine bone mineral density in osteoporosis. J Bone Miner Res 2000; 15:515-521.
53. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993; 91:1769-1774.
54. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 1996; 5:487-488.
55. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamilhagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS study. J Clin Endocrinol Metab 1997; 82:719-724.
56. Luukinen H, Kakonen SM, Pettersson K, Koski K, Laippala P, Lovgren T, Kivela SL, Vaananen HK. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 2000; 15:2473-2478.
57. Liu G, Peakcock M. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int 1998; 62:286-289.
58. Sugiyama T, Kawai S. Carboxylation of osteocalcin may be related to bone quality: a possible mechanism of bone fracture prevention by vitamin K. J Bone Miner Metab 2001; 19:146-149.
59. Garnero P, Dargent-Molina P, Hans D, Schott A.M, Bréart G, Meunier PJ, Delmas PD. Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EPIDOS prospective study. Osteoporos Int 1998; 8:563-569.
60. Johnell O, Oden A, De Laet C, Garnero P, Delmas PD, Kanis JA. Biochemical markers and the assessment of fracture probability. Osteoporos Int 2002; 13:523-526.
61. Garnero P, Mulleman D, Munoz F, Sornay-Rendu E, Delmas PD. Long-term variability of markers of bone turnover in postmenopausal women and implication for their clinical utility: the OFELY Study. J Bone Miner Res; (in press).
62. Akesson K, Liunghall S, Jonsson B, Sernbo I, Johnell O, Gardsell P, Obrant KJ. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: A retrospective and prospective population based study of women. J Bone Miner Res 1995; 10:1823-1829.
63. van Daele PLA, Seibel MJ, Burger H, De Laet CRDH, van Leeuwen JPTM Hofman A, Birkenhager JC, Pols HAP. Evidence for uncoupling of bone formation and bone resorption in women with hip fracture: A prospective study. Osteoporos Int 1996; 6(Suppl 1):S199.
64. Weel AEAM, Seibel MJ, Hofman A, van Leeuwen JPTM, Pols HAP. Which fractures are associated with high bone resorption in elderly women: The Rotterdam study. J Bone Miner Res 1999; 10(Suppl 1):S160.